Skip to content

A clinical randomized controlled trial and study on brain cortex activation in balance disturbance training for individuals with visual impairment

A clinical randomized controlled trial and study on brain cortex activation in balance disturbance training for individuals with visual impairment

Status
Recruiting
Phases
Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400082991
Enrollment
Unknown
Registered
2024-04-12
Start date
2023-05-14
Completion date
Unknown
Last updated
2024-04-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Visual impairment/balance dysfunction

Interventions

visual impairment:none
visual health:none
visual impairment-perturbation :perturbation based training*10times,3-4times/week for 3weeks

Sponsors

Shanghai Yangzhi Rehabilitation Hospital (Shanghai Sunshine Rehabilitation Center)
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: (1) Thevisually impaired group :corrected visual acuity 0.6 (2) 18-60 years old, male or female; (3) Good health, no lower limb joint trauma, muscle damage, infection, pain and other diseases, with independent standing and independent walking ability; (4) Hearing or corrected hearing 0-25dB; (5) positive responses to all questions on the Physical Activity Readiness Questionnaire (PARQ); (6) No cognitive impairment or communication impairment, Simple Intelligent State Examination (MMSE) = 24 points;

Exclusion criteria

Exclusion criteria: (1) Participate in high-intensity physical activities before the experiment, and have a history of balance training within three months; (2) Brain injury, cognitive impairment, diagnosed psychosis, major depression (suicidal tendencies) or epilepsy, family history of psychosis or epilepsy; (3) Any osteoarticular system injury or disease that affects the balance walking function, such as severe joint contractures, recent fractures of the trunk or lower limbs, osteoarthritis, osteoporosis, etc.; (4) Those who cannot tolerate serious systemic diseases such as cardiopulmonary diseases, and have serious systemic diseases such as diabetes and uremia; (5) Defects in hearing or vision (except for the visually impaired group) may affect the assessment and treatment; (6) Apply drugs that change the excitability of the cerebral cortex (anti-epileptic drugs, sedative hypnotic drugs, etc.); (7) Absent from more than one-third of the exercise session or unable to comply with the exercise plan; Severe diseases, adverse events or adverse reactions, the reaction cannot be tolerated;

Design outcomes

Primary

MeasureTime frame
step threshold test;Sensory Organization Test Score;Adaptation Test Score;HBO;Balance Test Score;

Secondary

MeasureTime frame
iEMG,RMS;single leg standing;confidence of balance/fall risk;Sensory test sensitivity;Aacceleration of Centre of Mass ;Physical activity level;

Countries

China

Contacts

Public ContactQI QI

Shanghai Yangzhi Rehabilitation Hospital (Shanghai Sunshine Rehabilitation Center)

qibuqi133@163.com+86 133 1162 6715

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026